Swedbank AB
Source: SEC Form 13F · as of Mar 2026Swedbank AB holds 14 biotech & pharma companies tracked by BioSniper, totaling $861.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$861.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 2,398,000 | $334.2M |
| JAZZJazz Pharmaceuticals plc | 992,108 | $187.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 215,590 | $166.6M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 792,187 | $44.8M |
| EXELEXELIXIS, INC. | 841,778 | $36.1M |
| INCYIncyte Corp. | 362,456 | $34.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 62,215 | $20.6M |
| INSMINSMED Inc | 82,865 | $13.6M |
| TEVATeva Pharmaceutical Industries Limited | 380,266 | $11.5M |
| SVRASavara Inc | 700,000 | $3.8M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 100,900 | $3.2M |
| IONSIONIS PHARMACEUTICALS INC | 32,253 | $2.4M |
| BBIOBridgeBio Pharma, Inc. | 27,600 | $2.0M |
| OLMAOlema Pharmaceuticals, Inc. | 55,100 | $822K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.